The blood based biomarker market is estimated to be valued at US$ 18.8 billion in 2022 and is expected to exhibit a CAGR of 12.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Blood based biomarkers are biological molecules found in blood that are indicators of normal or abnormal processes, or of conditions or diseases...
0 Commentarios
0 Acciones
1616 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian